Key result
Exenatide shows no reported clinical effect in patients with acute myocardial infarction.
Why the study?
Reperfusion injury after primary PCI in acute STEMI patients contributes to myocardial damage despite early reperfusion therapy.
Comparison
Additional treatment with exenatide vs standard care in acute MI patients
Design
Other
Authors
Loading...
Apoptosis acceleration during reperfusion may worsen STEMI outcomes in this cohort; leaves open whether targeted inhibition improves prognosis.
Bernink et al. (2012) studied Acute Myocardial Infarction. Exenatide was evaluated. The effect of additional treatment with exenatide in patients with acute myocardial infarction was not reported in the provided abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: